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Background: Systematic review methodology includes the rigorous collection, selection, and evaluation of data in
order to synthesize the best available evidence for health practice, health technology assessments, and health
policy. Despite evidence that sex and gender matter to health outcomes, data and analysis related to sex and
gender are frequently absent in systematic reviews, raising concerns about the quality and applicability of reviews.
Few studies have focused on challenges to implementing sex/gender analysis within systematic reviews.
Methods: A multidisciplinary group of systematic reviewers, methodologists, biomedical and social science
researchers, health practitioners, and other health sector professionals completed an open-ended survey prior to a
two-day workshop focused on sex/gender, equity, and bias in systematic reviews. Respondents were asked to
identify challenging or ‘thorny’ issues associated with integrating sex and gender in systematic reviews and indicate
how they address these in their work. Data were analysed using interpretive description. A summary of the findings
was presented and discussed with workshop participants.
Results: Respondents identified conceptual challenges, such as defining sex and gender, methodological
challenges in measuring and analysing sex and gender, challenges related to availability of data and data quality,
and practical and policy challenges. No respondents discussed how they addressed these challenges, but all
proposed ways to address sex/gender analysis in the future.
Conclusions: Respondents identified a wide range of interrelated challenges to implementing sex/gender
considerations within systematic reviews. To our knowledge, this paper is the first to identify these challenges from
the perspectives of those conducting and using systematic reviews. A framework and methods to integrate sex/
gender analysis in systematic reviews are in the early stages of development. A number of priority items and
collaborative initiatives to guide systematic reviewers in sex/gender analysis are provided, based on the survey
results and subsequent workshop discussions. An emerging ‘community of practice’ is committed to enhancing the
quality and applicability of systematic reviews by integrating considerations of sex/gender into the review process,
with the goals of improving health outcomes and ensuring health equity for all persons.
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Sound decisions about clinical interventions and about
implementation of health policies ideally require a
strong evidence base combined with judgment about
how the evidence could best be applied to a particular
patient and/or in a particular policy context. Systematic
reviews provide a framework, methods, and tools to
collate and analyse relevant evidence from primary* Correspondence: vrunnels@uottawa.ca
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unless otherwise stated.research. They are widely used to guide clinical, policy
and program decisions, conduct health technology as-
sessments, and determine directions for new research
[1-4]. They are also used to assess how interventions
may contribute to health equity [5]. However, many sys-
tematic reviews do not clearly address the applicability
of the evidence [6]. Of particular interest here, most do
not explicitly describe whether the evidence applies to
both women and men, nor analyse possible sex and
gender-related differences and similarities, nor indicate
when such data are missing [7,8].l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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processes that generally distinguish females from males
while gender refers to the roles, relationships, behav-
iours, relative power, and other traits that societies
generally ascribe to women, men, and people of diverse
gender identities (e.g., transgender persons) [9,10]. Al-
though often categorized as binary for analysis (e.g., male/
female; masculine/feminine), processes of sex/gender are
dynamic, multidimensional, and interactive [11-13]. Sex
and gender analysis, referred to here as sex/gender ana-
lysis to emphasize the interrelationships among the con-
cepts, is an analytical framework that is used to explore
possible biological and social similarities and differences
between and among men and women, boys and girls [9].
For example, in the context of health care systems, sex/
gender analysis explores the interrelationships of sex and
gender within or between groups in order to identify how
these may affect health experiences, access to care, and
health outcomes.
The lack of attention to sex/gender in systematic re-
views is of concern for several reasons. There is a substan-
tive and growing body of knowledge calling attention to
sex/gender-related differences in pharmacokinetics and
pharmacodynamics, genetic expression, and in prevalence,
onset, and severity of diseases such as auto-immune disor-
ders [14-21]. Research studies also identify sex/gender dif-
ferences in subjective experiences of conditions such as
depression and chronic pain, responses to health interven-
tions, the utilization of health care systems, and in many
other processes that influence health [22-25]. Failure to
consider whether such differences are clinically meaning-
ful, and how processes related to sex/gender may or may
not be relevant to a particular intervention, can result in
inappropriate application of findings and have harmful
implications for clinical outcomes and/or for the success
of health policies and programs [26,27].
Systematic reviews can also be used to help determine
which interventions reduce inequities in health, defined
as preventable and therefore unfair differences in health
between groups [28-31]. Explicitly identifying to whom
the evidence does or does not apply is necessary to for-
mulate social policy initiatives to reduce poverty and
other inequities and to determine what interventions are
appropriate with particular populations. It is widely rec-
ognized that sex/gender-related processes are determi-
nants of health – men, women, and persons of diverse
gender identities may experience disadvantages and
marginalization in different ways, both within and be-
tween communities [32-35]. Further, many forms of bias,
including publication bias (the tendency to publish posi-
tive rather than negative research findings); and outcome
reporting bias (the selective reporting of some outcomes,
but not others, depending on the nature and direction of
the results), are a major concern for systematic reviewmethods and can affect applicability and quality of stud-
ies [36]. Lack of reporting about sex/gender in system-
atic reviews can elevate risk of bias and limit reviewers,
researchers and other users of reviews from assessing in
what ways, and specifically for whom, interventions may
or may not be effective and may reduce or exacerbate
health inequities.
Furthermore, many research and governmental organi-
zations have policies mandating that sex/gender-related
issues be addressed in proposals for health research
funding, clinical trial design and registration, and in pol-
icy and program initiatives, citing the rationale that con-
sideration of possible sex/gender-related similarities and
differences is essential for good science, policies, and
programs [37-39]. Editors of a number of major health
journals are beginning to call for sex/gender policies to
enhance the quality and applicability of reporting of re-
search evidence [40-43].
Integrating sex/gender analysis into the processes and
methods of systematic reviews can enhance the applic-
ability and quality of reviews, with the long term goals
of improving health outcomes and reducing health in-
equities. While many review authors, editors, and group
coordinators acknowledge there is value to considering
sex/gender, they point to challenges in implementing
such analysis. To address these concerns, our Working
Group on Sex and Gender Analysis in Systematic
Reviewsa convened a meeting of review authors, review
group coordinators and editors, methodologists, health
practitioners, biomedical and social science researchers,
consumers, and funders to discuss the factors that hin-
der the integration of sex/gender analysis within system-
atic reviews and to outline priorities for addressing these
challenges. Invited participants were individuals we
knew or were known to us through research, academic,
and policy networks as possessing knowledge, practical
experience, and expertise in relation to systematic re-
views and/or in the application of sex/gender analysis to
health evidence. To our knowledge, this paper is the first
to identify the challenges of integrating sex/gender ana-
lysis in systematic reviews from the perspectives of those
conducting and using systematic reviews.
Methods
A brief, open-ended survey was distributed by email two
weeks prior to a two-day workshop focused on sex/gen-
der, health equity, and bias in systematic reviews.b Those
invited were asked to briefly describe their backgrounds,
how they came to be interested in systematic reviews
and quality in health research, and what outcomes
they would like to see from the meeting. The central
questions asked were: “What do you perceive to be the
challenges of incorporating sex/gender, equity, and bias
in systematic reviews? What are some of the most
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have emerged in your work with systematic reviews?
and How have you attempted to address these?” [Res-
pondents could select challenges and/or ‘thorny’ issues
to address the latter question]. The main goals of the
survey were to provide organizers with a better under-
standing of the interests of workshop participants in sys-
tematic reviews and/or in sex/gender-related issues, to
identify a diverse range of challenges beyond what we
might have considered, and to encourage respondents to
think about challenges and possible solutions to better
inform workshop discussions.
Analysis
All responses to the questions were coded systematically
by one analyst (VR) using qualitative data analysis soft-
ware to organize the coded responses.c Units of coding
were determined as having discrete meaning as the ana-
lyst interpreted them [44-46]. The data were analyzed in
accordance with qualitative description, a low-inference
interpretive approach to qualitative data analysis, and
designed specifically for the purpose of description
[44,47]. Each unit was first organized and then coded as
a response to a specific question. Some responses were
assigned more than one code, where appropriate. Subse-
quently, data were analyzed across the organized codes
(i.e., in response to the questions posed) to look for pat-
terns or themes in the coding. Raw data, analysis, and
coding were shared and discussed with a second analyst
(ST); adjustments to coding and analysis were made by
consensus. A summary of the analyzed results were
presented to all 33 workshop participants, including
graduate students, an invited discussant, and several re-
searchers who had not been part of the survey.
For reporting purposes, all possible identifiers of re-
spondents were removed from the survey texts. Quota-
tions are denoted by quotation marks and reported
anonymously by respondent number. Ethical commit-
ments to anonymity and confidentiality, while limiting
description of individuals, also provides the conditions
in which we can generally assume the truthfulness of re-
spondents. Ethical approval was granted by the Univer-
sity of Ottawa Research Ethics Board.
Results
A total of 23 of 24 individuals who accepted an initial in-
vitation to attend the workshop responded to the survey.
Of the 23 respondents, 3 were men and 20 were women.
The estimated ages of respondents ranged from the late-
20s to late-60s. Respondents came from a variety of aca-
demic, clinical, health policy and other experiential
backgrounds and included university-affiliated and inde-
pendent researchers, research coordinators and health-
related professionals, some of whom were affiliated withnon-governmental health organizations. Systematic re-
views were used by respondents as sources of evidence
for academic work, clinical practice, and/or policy devel-
opment. Of the 23 respondents, 14 had experience with
systematic reviews either as members of teams who con-
duct reviews or as contributors or advisors concerning
review content or methods. Most were members of
Cochrane and Campbell Collaborations’ methods and re-
view groups and several were affiliated with other research
organizations conducting reviews. Nine of the 23 respon-
dents indicated a primary expertise in the area of sex/gen-
der analysis. The respondents’ combined experience with
systematic reviews and/or sex/gender was extensive and
they formed a multi-disciplinary group with diverse aca-
demic backgrounds, approaches, and discourses.
Respondents provided rich and detailed answers to the
questions, placing particular emphasis on the identifica-
tion of challenges and thorny issues. No respondents of-
fered examples of how they addressed these issues in
their work. All respondents identified expected out-
comes from the workshop. A summary of the results is
provided in the following sections.
Challenges and thorny issues
Analysis of the data revealed a number of common
themes among the perceived challenges to integrating
considerations of sex/gender in systematic reviews.
These have been organized into four main interrelated
categories: 1) conceptual challenges; 2) methodological
challenges; 3) challenges related to availability and qual-
ity of data; and 4) practical and policy challenges.
Conceptual challenges
Clarifying the concepts of ‘sex and gender’ and putting
concepts into practice in systematic reviews were identi-
fied as significant challenges. Respondents noted the ten-
dency for sex to be used as a proxy for gender and that
the terms sex and gender were used interchangeably:
“One tricky thing has been the lack of clarity around
whether it is gender or sex or both being reported in
primary studies and in reviews. This makes us have to
use the ever-ambiguous ‘and/or’ much of the time”
(Respondent #6).
“Some reviewers (and other clinical researchers) may
still be unclear about the concepts of ‘sex’, ‘gender’,
‘equity’, ‘race/ethnicity’, etc. and how to incorporate
these” (Respondent #21).
Others pointed to the complexity of the concepts of
sex and gender, indicating that they are not single vari-
ables, but interrelated biological and social processes that
in many ways have yet to be understood. Respondents
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experts and systematic reviewers to provide clarity and
guidance on capturing the nuanced and intersecting na-
ture of sex/gender particularly within the context of sys-
tematic reviews.
Beyond the definitional challenges, respondents called
attention to broader conceptual challenges that often
manifest within interdisciplinary projects. Specifically,
respondents raised concerns about the construction of
knowledge and ‘what counts’ as evidence and the chal-
lenges these present to incorporating sex/gender analysis
into systematic reviews. The absence of sex/gender con-
siderations within systematic reviews was traced back to
what influences how knowledge is produced:
“The biggest challenges are much more fundamental
and have to do with the way that we arrive at
decisions as to what is important for us to study, why
it is important for us to study, and how we determine
the way to study and ultimately produce evidence”
(Respondent #3).
“The emergence of an evidence-based medicine
approach has altered…our understanding of how to
identify credible evidence and how to synthesize
that evidence to inform medical practices as well
as policies and programs… This approach to
evidence, knowledge and policy-making has
profound effects on who is authorized to provide
credible accounts, what counts as credible evidence,
and what counts as credible synthesis and
translation” (Respondent #16).
The assumptions about ‘credible’ evidence were seen
to have particular implications for the inclusion of sex/
gender analysis in systematic reviews because sex-
disaggregated data and sex/gender differences and simi-
larities are often not taken into account in the research
design, conduct, data analysis, and reporting of ran-
domized controlled trials that form the basis of most
reviews. In studies that include both men and women,
conclusions are often presented as applicable to all
‘subjects’. This is, in part, related to a history of ex-
cluding women in adequate numbers from many clin-
ical trials and the assumption that findings from
studies of men could be extrapolated to women [48].
As respondents noted:
“Over time, I realised that women were being excluded
from the development of evidence in a variety of
ways… (and this had implications for) who were
scientists, who defined the questions, who were subjects
in research, what conditions were studied…”
(Respondent #11).“[My] concern is a lack of examination of sex/gender
and other diversity within systematic reviews. There
are important differences but does the current
methodology hide those differences or fail to examine
them… (Respondent #14).
Dealing with diversity and heterogeneity of popula-
tions was a significant methodological challenge de-
scribed by respondents as detailed below.
Methodological challenges
Methodological issues generated the largest amount of
commentary. Some respondents expressed concerns
about a lack of transparency in clinical trial design, out-
comes, and reporting current practices which have im-
plications for the quality of systematic reviews:
“There is a lack of transparency about clinical trial
design, including a priori outcomes and analyses, or
poor quality protocols. There is insufficient reporting of
methodologic information in current trial registries…”
(Respondent #21).
The quality of reporting in primary studies has a cas-
cading effect on reviews and on the analyses that can be
completed:
“There are many perplexing issues with regards to
conduct of systematic reviews. The most profound is
quality of reporting. The quality of reporting directly
leads to the comprised validity of systematic reviews,
as well as contributing to the assessment of clinical
heterogeneity which is a complex issue often overlooked
by reviewers.” (Respondent #10).
In particular, respondents noted that sex and gender
and other health determinants are often neglected in the
single studies that form the basis of reviews. They identi-
fied major challenges to both primary studies and sys-
tematic reviews:
“…determining ways of measuring equity and bias,
challenges of being able to capture complex social
processes in what we mean by incorporating sex/
gender.” (Respondent #5).
“… [the] question to ask is both related to quality of
the research being reported and sorting out when, if, or
how sex and gender matter.” (Respondent #11).
“There needs to be more work undertaken to explore
how to identify and synthesize evidence on
interventions to address structural determinants of
health/health equity.” (Respondent #16).
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through use of a range of data sources and a variety of
research designs:
“I’m wondering about the methodology and quality of
the reviews that incorporate these different research
designs and how we can use all the literature, not just
the quantitative…to ensure a comprehensive overview
of the literature, including grey literature, when we are
making context-sensitive, evidence-based decisions.”
(Respondent #14).
Respondents noted a lack of available tools, checklists,
and/or outlines for conducting sex/gender analysis within
primary studies and systematic reviews. Tools and check-
lists are practical aids that incorporate recognition and
understanding of what sex/gender can mean when applied
into practice, and were seen as essential for those new to
the concepts of sex/gender. It was recognized, that “tools
are still in development and lagging behind the theoretical
arguments for inclusion of these issues” (Respondent #9).
While tools are essential, caution was expressed about
relying too heavily on a tool to conduct complex analyses:
“I struggle with the fact that I have not been able – and
I am reluctant to anyway – turn sex- and gender-based
analysis (or any other form of equity analysis) into a set
checklist of questions and techniques. To date, my
experiences have taught me that these analyses are more
fluid and emergent than predictable, and depend on the
history of research and evidence in the field, the framing
of the question, the sources of data available, whether
sex disaggregated data are available, how researchers
operationalize the two concepts and the context of the
question.” (Respondent #13).
Moving from the analytical framework of sex/gender
analysis towards appropriate and robust methods to ad-
dress these concepts in systematic reviews raised add-
itional challenges. Respondents warned about pitfalls
when developing appropriate methods to integrate sex/
gender in systematic reviews. In particular, they recog-
nized that subgroup analyses are an important tool for
investigating heterogeneity and examining results for
men and women separately, but such analyses raise im-
portant technical and interpretive challenges:
“Heterogeneous outcomes and small studies make
robust subgroup analysis difficult to complete.”
(Respondent #3).
“Few primary studies pre-specify subgroup analyses or
acknowledge the limitations of analyses as hypothesis-
generating. Over-interpretation of results (emphasis onthe subgroup analysis rather than the primary
outcome) and subsequent claims also present
challenges when the emphasis is on subgroup analysis
rather than the primary outcome, and give rise to
potential for publication bias, and spurious (not to
mention some notorious…) subgroup claims in the
literature.” (Respondent #21).
On the other hand, respondents considered it import-
ant to address the implications of potential sex/gender-
based differences and equity issues in relation to health
conditions and interventions:
“Reviewers may not recognize that even small
differences in the magnitude of treatment effect could
translate into meaningful differences to consider in
risk-benefit ratios.” (Respondent #21).
Respondents acknowledged that methodological chal-
lenges, such as quality of data reporting and appropriate
subgroup analyses, were not unique to sex/gender con-
siderations but were of general concern to systematic re-
viewers. However, they identified a specific need for
dialogue and guidance on the application of sex/gender
analysis to systematic review methods:
“[There is a] need for appropriate guidance and
training for both trialists and systematic reviewers and
for leadership in methods, and examples of applying
these methods.” (Respondent #17).
Challenges related to availability and quality of data
Linked to the methodological issues were challenges re-
lated to the availability and quality of data needed to
conduct a robust review: these challenges became par-
ticularly marked when matters of sex/gender were con-
sidered. Many commented on the lack of data about
women, lack of sex-disaggregated data, and/or inconsist-
encies in reporting such data:
“[There is a] lack of sex-disaggregated data in published
studies. Lack of transparency in published studies, for
example, cases where some outcomes are reported for
both men and women and others are not, without
explanation…. [I was] working on a review that
examined a health issue specifically among women. It
was challenging to find data on women to conduct the
review. This stimulated questions around quality, the
questions researchers ask and the answers that result
from these very specific questions.” (Respondent #3).
“Original studies do not include the kind of
disaggregated data that might allow secondary sex/
gender analyses to be carried out.” (Respondent #12).
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were regarded as issues of data quality that affect the
conduct of systematic reviews generally. These were seen
to stem from “…lack of transparency, access to all the
studies, all measured outcomes in studies and to the ori-
ginal data that might allow additional questions to be
answered” (Respondent #12). Respondents also pointed
to the potential for serious consequences from the ab-
sence, omission or other shortcomings in data gathering,
analysis, and reporting, such as failure to include data
about adverse events.
“A ‘thorny’ issue that deserves special mention is how
to find, adequately assess, and incorporate harms data
into intervention systematic reviews. This is a
consistent problem due to poor quality reporting and/
or measurement, suppression of data or delays in
publication, short duration of follow-up, and a lack of
representation of potentially vulnerable populations
for whom the intervention is ultimately targeted.”
(Respondent #21).
In particular, if questions regarding sex and gender
were not asked, either when conducting single trials or
systematic reviews, then the data would not be available
to answer questions about possible differences in treat-
ment effects for women or men.
“I think there is an assumption by some, that if the
treatment works, why wouldn't it work for everybody?
And for those convinced of the importance, many will
consider it a great effort to try to obtain this
additional data from the authors of the original
studies.” (Respondent #19).
In essence, the non-availability and/or non-reporting
of data created an iterative cycle in which questions
about sex/gender were repeatedly left out. Respondents
aptly summarized this issue:
“Questions not asked and therefore not answered.”
(Respondent #3).
“…the questions that are asked are often driven by the
data that are available [so that] there is some
resistance to asking sex/gender/diversity questions.”
(Respondent #13).
These challenges underscore the importance of sys-
tematic reviews in driving reporting standards for pri-
mary studies. Emerging guidance on the use of sex/
gender analysis in systematic reviews encourages authors
to report what is known and not known about effective-
ness of the intervention reviewed [49].Practical and policy challenges
In addition to the difficulties of obtaining sex-disaggregated
data, and a lack of tools, respondents identified other
practical challenges to integrating sex/gender in system-
atic reviews in health. These included an absence of
‘model’ reviews to illustrate how sex/gender analysis could
be carried out:
“There are still relatively few examples of solid
Cochrane reviews that incorporate a consistent
approach to sex and gender analysis and equity
analysis.” (Respondent #20).
Other practical challenges dealt with the realities of
working in a research intensive environment with com-
peting demands and expanding workloads. Respondents
cited experiences of resistance or ‘push back’ to incorp-
orating considerations of sex, gender, and equity in sys-
tematic reviews “…from authors and review groups who
feel overwhelmed with the workload already demanded
of them” (Respondent #9). Respondents also discussed
realities of publishing, noting “[there is] difficulty finding
journals that think this sort of research has merit” (Re-
spondent #7). In order to address these challenges, re-
spondents saw the need for researchers, reviewers and
editors to be aware of the substantive and growing body
of health evidence addressing sex/gender similarities and
differences in relation to health outcomes. A critical
mass of evidence was considered integral to support the
merit of such studies.
Respondents also identified several policy challenges
that were system level and generally fell outside the
scope of systematic review practice. Relating to earlier
challenges about the availability of data, respondents
described a need for policies that would mandate trans-
parency in research and data collection, calling for in-
creased transparency and more complete reporting of
methodological information in current trial registries.
These issues have important implications for the quality
of systematic reviews.
“[There is] a lack of binding guidance on the
part of regulatory agencies and funders of clinical
trials to collect the data in a pre-specified
manner, and to make the data publicly available.”
(Respondent #21).
The types of decisions required to address these chal-
lenges are typically made and funded by higher levels of
government or quasi-governmental bodies that imple-
ment government directions into policy. However, sys-
tematic reviewers working at the ‘coalface’ of reported
study data have an important role to play in advocating
for such policy changes.
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While respondents described the challenges and thorny
issues in detail, no one answered the question, “How
have you attempted to address these?” However, respon-
dents did propose a range of outcomes they hoped
would emerge from the workshop. These proposed out-
comes indicate how some of the identified challenges
could be approached and eventually addressed. Proposed
outcomes included developing methods guidelines and/
or a series of methods papers to provide a framework
and practical ways to integrate sex/gender analysis in
systematic reviews and in peer review; refining current
tools and checklists for the design and appraisal of re-
views and/or developing new tools; and establishing
cross-disciplinary collaborations through a ‘community
of practice’. Respondents sought ways to determine the
“threshold of important differences” of sex/gender (Re-
spondent #13), the influence of sex/gender “on the sum-
mary effects in a systematic review” (Respondent #1),
and “the key ideas to help increase the sex/gender rele-
vance of reviews…the minimum to consider to maximize
the impact” (Respondent #8). Through joint efforts, col-
laborators could share resources, conduct research, in-
cluding model reviews, and provide educational fora,
training and outreach to biomedical and social scientists,
practitioners, peer reviewers, journal editors, funders
and policy makers interested in the quality and applicabil-
ity of health evidence. Collaboration might also result in
“a strategy to encourage funding agencies and regulatory
agencies to require the collection of key data related to is-
sues of sex/gender, equity, and bias in publicly funded tri-
als, full disclosure of study results, and the publication of
protocols” (Respondent #21). Many of these suggestions
laid the basis for initiatives discussed below.
Discussion
Systematic review methodology provides a framework
and structure for the collection, analysis, synthesis, and
reporting of data, and notably in the case of Cochrane
Reviews, strict protocols and methodological approaches
that are regularly reviewed and updated [1]. However,
despite considerable research demonstrating that sex-
and gender-related processes often matter to health out-
comes and an increasing number of institutional policies
supporting sex/gender analysis in health research and
reporting, these issues remain largely unknown or disre-
garded. This is the case for many areas of medical and
clinical research, health technology assessment, and in
conducting systematic reviews [7,50]. Asking a multidis-
ciplinary group of individuals who conduct and/or use
systematic reviews to identify what they considered to
be major challenges to addressing sex/gender analysis in
reviews proved invaluable to scope out key conceptual,
methodological, practical, and policy issues.In particular, respondents recognized that integrating
sex/gender analysis in systematic reviews is an important
step forward to answer the question “to whom does the
evidence apply and to whom might it not apply?” in
order to make sound clinical and policy decisions. They
sought greater clarity in defining the concepts of sex and
gender and guidance in operationalizing these concepts
in the context of systematic reviews. Requests for clarity
and guidance were not surprising given that these
concepts have been re-defined since the 1970s by Ann
Oakley, Nancy Krieger and other researchers and theore-
ticians, to transcend narrow assumptions of biological
determinism in relation to women’s health, and that
international research bodies, health organizations, and
academic researchers continue to develop analytic
frameworks to address sex/gender in more nuanced
ways [12,51-53]. As some respondents suggested, this in-
volves seeing sex and gender as more than discrete vari-
ables or part of a checklist of items to be ‘controlled for’,
but as dynamic and entangled biological and social pro-
cesses that shape human health and cross-cut other
health determinants.
It was also clear from responses to the survey ques-
tions that respondents, a majority of whom had expert-
ise in systematic review methodology, recognized the
many limitations to the quality of evidence in primary
studies, systematic reviews, and meta-analyses. These
perspectives were evident in comments about poor qual-
ity protocols; the lack of transparency in clinical trial
design; inadequate reporting of outcomes, including ad-
verse events; in the challenges of conducting sub-group
analyses; and in addressing the many forms of methods
bias in appraisal of evidence. As Ioannidis and others
have shown, seemingly rigorous methods have consider-
able strengths, “but can also lead to wrong or misleading
answers” [54, p. 169]. For example, the outcomes of
meta-analyses on the same topic may differ widely due
to many factors, including that those conducting/spon-
soring the meta-analyses may choose different data
sources, search strategies, inclusion/exclusion criteria for
eligible populations, and have different, sometimes con-
flicting interests that may influence how results are pre-
sented and interpreted [54].
Systematic reviewers who choose to include consider-
ations of sex/gender and equity in their protocols are often
limited by the absence of relevant data in primary research
studies. Decisions taken early in the research process have
implications for the subsequent synthesis of evidence. As
some respondents noted, asking questions about the
potential relevance of sex/gender-related processes to the
research question or intervention at the protocol stage of
systematic review design can help, for example, to clarify
baseline from effect differences and pre-empt other gaps
and omissions with regard to sex/gender.
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Cochrane Collaboration and within the larger systematic
review community as to how knowledge is produced, ap-
praised and translated into practice, and in the theory
and logic behind interventions [36,55-59]. Several groups
are engaged in work to increase the quality and applic-
ability of systematic reviews and in particular, to address
issues of health equity [6,60]. Current guidelines, includ-
ing the Cochrane and Campbell Health Equity checklist
[61], and the Equity Extension of PRISMA (Preferred
Reporting Items for Systematic Reviews and Meta-
Analyses) [62], are examples of tools beginning to in-
corporate consideration of sex/gender. There is also
increased interest in addressing context in reviews, for
example, by incorporating qualitative evidence about
who may or may not be affected by particular health in-
terventions, in what ways, and why, including relevant
cultural and historical conditions [63,64]. Attention to
context can broaden the scope and methods of reviews
to better integrate sex/gender analysis, and consider-
ations of equity.
Conclusions
The results of this survey identified challenges and
‘thorny’ issues associated with sex/gender in systematic
reviews and emphasized that methods to integrate sex/
gender analysis in reviews are still in the early stages of
development. To begin to address these challenges,
workshop participants suggested a number of priority
items and collaborative initiatives, including the develop-
ment of resources, such as ‘briefing notes’ and methods
papers, to guide reviewers in the design and appraisal of
systematic reviews. As part of such guidance, reviewers
are encouraged, at a minimum, to disaggregate data by
sex; conduct subgroup analyses, when possible, or indi-
cate why analyses could not be performed; and address
the question: To whom does this evidence apply?
Reporting what is known and not known about sex/gen-
der transparently highlights gaps in available data, con-
tributes to future research questions, and reinforces
awareness about the need for improved reporting prac-
tices about sex/gender in primary studies.
The many challenges identified in the survey may also
help to explain why existing policies that encourage and/
or mandate the integration of sex/gender analysis in
health research are not consistently implemented. Such
policies and guidelines are necessary to raise awareness
of sex/gender considerations, redress past exclusions of
women, minorities and others from clinical trials and
improve the quality of health evidence: they require pol-
itical will, direction and monitoring to ensure implemen-
tation. Based on responses to the survey and subsequent
workshop discussions about the conceptual, methodo-
logical, practical, and policy challenges of integratingsex/gender analysis in systematic reviews, we suggest
that the implementation of existing sex/gender policies
and guidelines should be supported and reinforced
through opportunities for training, collaborative pro-
jects, and cross-disciplinary dialogue among a range of
stakeholders, including trial sponsors, researchers, sys-
tematic reviewers, policy makers, journal editors, re-
search ethics boards and peer review bodies.
Spurred by the challenges and priorities identified at
the workshop, a community of practice has emerged
among those with expertise and interest in sex/gender
analysis, health equity, and systematic review method-
ology to integrate sex/gender analysis into the practice
of systematic reviews. Participants are working together
to enhance the quality and applicability of systematic re-
views, with the goals of improving health outcomes and
health equity for all persons.
Endnotes
aSee: http://equity.cochrane.org/sex-and-gender-analysis.
b“Combining Forces to Improve Systematic Reviews:
Gender, Equity and Bias”, funded by the Canadian Insti-
tutes of Health Research (Grant#109018).
cNVivo qualitative data analysis software Version 8
2008. Doncaster, Australia: QSR International Pty Ltd.
[http://www.qsrinternational.com].
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